Endocrine disrupting compounds and prostate cancer
To access this article, please choose from the options below
PII: S0304-3835(05)00915-8
doi:10.1016/j.canlet.2005.10.006
© 2006 Elsevier Ireland Ltd. All rights reserved.
PII: S0304-3835(05)00915-8
doi:10.1016/j.canlet.2005.10.006
© 2006 Elsevier Ireland Ltd. All rights reserved.